InnovAge
INNV
$3.95
Share price
-1.25%
Change (1 day)
-37.30%
Change (1 year)
Categories
Earnings for InnovAge (INNV)
Earnings in 2023 (TTM): -$34.63 M
According to InnovAge's latest financial reports the company's current earnings (TTM) are -$34.63 M. In 2022 the company made an earning of -$50.8 M a decrease over its 2021 earnings that were of $8.72 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for InnovAge from 2020 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | -$34.63 M | -31.82% |
| 2022 | -$50.8 M | -681.94% |
| 2021 | $8.72 M | -388.91% |
| 2020 | -$3.03 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Merck MRK | $3.03 B | -8,864.58% | 🇺🇸 USA |
 Cocrystal Pharma
COCP | -$21.24 M | -38.67% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | -$10.29 M | -70.29% | 🇺🇸 USA |
 Horizon Therapeutics
HZNP | $0.51 B | -1,580.14% | 🇮🇪 Ireland |